News Formal

CGS-CIMB sees decent earnings growth for Pharmaniaga, reiterates ‘add’ call

  • 📰 malaymail
  • ⏱ Reading Time:
  • 18 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 86%

Sverige Nyheter Nyheter

Sverige Senaste nytt,Sverige Rubriker

KUALA LUMPUR, June 28 — CGS-CIMB Securities Sdn Bhd (CGS-CIMB) is positive on Pharmaniaga Bhd (Pharmaniaga) on the expectation of a decent financial year 2023-2024 (FY23-24)...

KUALA LUMPUR, June 28 — CGS-CIMB Securities Sdn Bhd is positive on Pharmaniaga Bhd on the expectation of a decent financial year 2023-2024 earnings growth for the company.

“The ample excess production capacity at Pharmaniaga’s existing plants will allow it to ramp up output in the next three to five years — in light of rising pharmaceutical demand and new product launches — with little to no incremental capital expenditure, thus potentially leading to better economies of scale and margins,” it said.

 

Tack för din kommentar. Din kommentar kommer att publiceras efter att ha granskats.
Vi har sammanfattat den här nyheten så att du kan läsa den snabbt. Om du är intresserad av nyheterna kan du läsa hela texten här. Läs mer:

 /  🏆 1. in SE

Sverige Senaste nytt, Sverige Rubriker

Similar News:Du kan också läsa nyheter som liknar den här som vi har samlat in från andra nyhetskällor.

V S Industry’s counter measures prove effectivePETALING JAYA: V S Industry Bhd is projected to sustain a positive outlook on revenue growth despite rising cost pressures and labour shortages, which had caused a decline in its operating efficiency.
Källa: staronline - 🏆 4. / 75 Läs mer »